MRONJ risk of adjuvant bisphosphonates in early stage breast cancer

被引：0

作者：

V. Patel

J. Mansi

S. Ghosh

J. Kwok

M. Burke

D. Reilly

N. Nizarali

C. Sproat

K. Chia

机构：

[1] Dept of Oral Surgery,Department of Oncology

[2] Guys & St Thomas' NHS Foundation Trust,undefined

[3] Fl 23,undefined

[4] Tower Wing,undefined

[5] Great Maze Pond,undefined

[6] London,undefined

[7] SE1 9RT,undefined

[8] Guys & St Thomas' NHS Foundation Trust,undefined

[9] Fl 23,undefined

[10] Tower Wing,undefined

[11] Great Maze Pond,undefined

[12] London,undefined

[13] SE1 9RT,undefined

[14] Sedation and Special Care,undefined

[15] Guys & St Thomas' NHS Foundation Trust,undefined

[16] Fl 23,undefined

[17] Tower Wing,undefined

[18] Great Maze Pond,undefined

[19] London,undefined

[20] SE1 9RT,undefined

来源：

British Dental Journal | 2018年 / 224卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Highlights that bisphosphonates continue to be the most common drug implicated in medication-related osteonecrosis of the jaw.Shows that an additional use of bisphosphonates has been indicated and now a further 20,000 women may be prescribed the medication and be exposed to the risk of jaw necrosis.Suggests the burden of additional dental assessment for these patients will fall upon GDPs.Introduces a new communication idea of the dental alert card which provides a warning to dentists for 'at risk' patients.

引用

页码：74 / 79

页数：5

共 50 条

[31] Optimizing adjuvant chemotherapy in early-stage breast cancer
Perez, Edith
Muss, Hyman B.
ONCOLOGY-NEW YORK, 2005, 19 (14): : 1759 - 1767
[32] Adjuvant Hormonal Therapy for Early-Stage Breast Cancer
Burstein, Harold J.
Griggs, Jennifer J.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (03) : 639 - +
[33] Potential use of bisphosphonates in the prevention of metastases in early-stage breast cancer
Coleman, Robert
CLINICAL BREAST CANCER, 2007, 7 : S29 - S35
[34] The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany
Fick, Eva-Maria
Katalinic, Alexander
Waldmann, Annika
CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 747 - 756
[35] Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
Allan Lipton
Breast Cancer Research and Treatment, 2010, 122 : 627 - 636
[36] INFLUENCE OF ADJUVANT BISPHOSPHONATES AND DENOSUMAB ON BREAST CANCER OUTCOMES
Coleman, R.
OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S93 - S93
[37] Optimal Use of Adjuvant Bisphosphonates and Breast Cancer Reply
Dhesy-Thind, Sukhbinder
Fletcher, Glenn G.
Clemons, Mark
Van Poznak, Catherine
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2720 - +
[38] Adjuvant Bisphosphonates in Postmenopausal Women with Breast Cancer in Lanarkshire
Park, D.
Abdullah, T.
CLINICAL ONCOLOGY, 2019, 31 (07) : E113 - E113
[39] Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
Lipton, Allan
BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (03) : 627 - 636
[40] Adjuvant bisphosphonates in breast cancer: has the time come?
Gagliato, Debora
Chavez-MacGregor, Mariana
BREAST CANCER MANAGEMENT, 2013, 2 (04) : 327 - 337

← 1 2 3 4 5 →